All NIH Exclusive Licenses (updated August 2017)
 Share
The version of the browser you are using is no longer supported. Please upgrade to a supported browser.Dismiss

 
View only
 
 
ABCDEFG
1
Year in Agreement Number (or as designated by NIH FOIA response)Agreement NumberLead InstituteApplicant Company IDDate EffectiveTerritory or Field Of UseTitle
2
1975L-100-1975/0Amicon Corporation3/3/1975CELL CULTURE ON SEMI-PERMEABLE TUBULAR MEMBRANES
3
1976L-100-1976/0Merck Sharp & Dohme, Corp.10/18/1976VACCINE FOR HEPATITIS
4
1977L-002-1977/0FDA/Spiral Systems5/17/1977Instrumental Method for Plating and Counting Aerobic Bacteria
5
1977L-101-1977/0
Cutter Group of Miles Laboratories, Inc.
6/28/1977VACCINE AGAINST VIRAL HEPATITIS PROCESS
6
1979L-001-1979/0NCI/DCTDCalbiochem-Behring Corp.1/30/1979Research reagentsSynthesis, Structure, and Anti-tumor Activity of 5,6 Dihydro-5-Azacytidine
7
1979L-002-1979/0NIDDK/Aldrich Chemical Company Inc8/7/1979Aminonaphthalimide Dyes for Intracellular Labelling
8
1980L-098-1980/0Bristol-Myers Squibb Company9/30/1979CIS-PLATINUM (II0 COMPLEXES
9
1980L-097-1980/0EM/Collaborative Research, Inc.1/1/1980HOMOFOLIC ACID DERIVATIVES
10
1980L-099-1980/0NIDDK/Andrulis Research Corporation2/5/1980FLUORESCENT DYES
11
1980L-102-1980/0NIDDK/Molecular Probes, Inc.2/13/1980Aminonaphthalimide Dyes for Intracellular Labelling
12
1980L-100-1980/0NHLBI/Kontes6/26/1980
HORIZONTAL FLOW-THROUGH COIL PLANT CENTRIFUGE WITHOUT ROTATING SEALS
13
1980L-001-1980/0NIDDK/Polysciences, Incorporated7/8/1980manufacture use and sellAminonaphthalimide Dyes for Intracellular Labelling
14
1980L-004-1980/0NHLBI/Fresenius KG Pharma8/14/1980Blood Cell Separator
15
1980L-101-1980/0NCRR/Litton Medical Electronics Division8/27/1980FIBER OPTIC PH PROBE AND DYE FIXATION BY COPOLYMERIZATION
16
1980L-003-1980/0NCRR/Roche Laboratories, Inc.9/26/1980Fiber Optic pH Probe and Dye Fixation by Copolymerization
17
1980L-002-1980/0Starks Associates, Inc.11/4/1980
Multi-Step Process For The Production of Methanesulfon-M-Anisidide, 4'-(9-Acridinylamino)-
18
1980L-005-1980/0Bristol-Myers Squibb Company12/4/1980
Multi-Step Process For The Production of Methanesulfon-M-Anisidide, 4'-(9-Acridinylamino)-
19
1981L-009-1981/0NHLBI/American Bentley, Inc.1/1/1981Oximeter for Monitoring Oxygen Saturation in Blood
20
1981L-012-1981/0NCI/ODBehringwerke Aktiengesellschaft1/1/1981N-Phosphonyl-Aspartato (1,2 diaminocyclohexane) platinum (II)
21
1981L-111-1981/0CC/Marion Laboratories, Inc.1/1/1981
Fecalator, an Apparatus and Method for Concentration of Parasite Eggs and Larvae
22
1981L-102-1981/0NIMH/Neurobiological Systems, Inc.2/18/1981
RADIORECEPTOR ASSAY FOR BENZODIAZEPHINES IN PLASMA AND OTHER BIOLOGICAL SPECIMENS
23
1981L-011-1981/0NIAID/Behringwerke Aktiengesellschaft3/4/1981Nuclease Resistant Hydrophilic Complex of Polyriboinosinic-Polyriboctidylic Acid
24
1981L-100-1981/0NHLBI/Buchi Laboratoriums-Technik AG4/14/1981CHROMOTOGRAPHY
25
1981L-002-1981/0NICHD/Calbiochem-Novabiochem Corp.5/1/1981ALLNONDENATURING ZWITTERIONIC DETERGENTS FOR MEMBRANE BIOCHEMISTRY
26
1981L-007-1981/0NCRR/Advanced Technology Labs, Inc.5/8/1981Fiber Optic ph Probe and Dye Fixation by Copolymerization
27
1981L-003-1981/0NICHD/Polysciences, Incorporated6/17/1981ALLNONDENATURING ZWITTERIONIC DETERGENTS FOR MEMBRANE BIOCHEMISTRY
28
1981L-005-1981/0NICHD/Serva Electrophersis6/22/1981ALLNONDENATURING ZWITTERIONIC DETERGENTS FOR MEMBRANE BIOCHEMISTRY
29
1981L-101-1981/0NHLBI/Kontes6/30/1981
PREPARATIVE COUNTERCURRENT CHROMATOGRAPHY WITH A SLOWLY ROTATING HELICAL TUBE ARRAY
30
1981L-001-1981/0ORS/Beecher Company9/14/1981All Fields-Plasma Clot Lysing TimerPlasma Clot Lysis Timer
31
1981L-006-1981/0NCI/ODOrtho Pharmaceutical Corporation9/25/1981All
METHOD FOR THE USE OF ORALLY ADMINISTERED 13-CIS- RETINOIC ACID IN THE TREAMENT OF ACNE
32
1981L-004-1981/0NICHD/Pierce Biotechnology, Inc.9/29/1981ALLNONDENATURING ZWITTERIONIC DETERGENTS FOR MEMBRANE BIOCHEMISTRY
33
1981L-103-1981/0NCI/ODWestwood Pharma./Bristol Myers11/2/1981
METHODS FOR USE OF ORALLY ADMINISTERED 13-CIS-RETIONIC ACID FOR TREATMENT OF DERMATOPATHIES
34
1981L-104-1981/0NHLBI/Industrial Inventions, Inc.11/1/1982Oximeter For Monitoring Oxygen Saturating In Blood
35
1982L-010-1982/0NIDDK/New England Nuclear1/1/1982make use and sellIRREVERSIBLE ANTI-GLUCOCORTICOIDS.
36
1982L-103-1982/0FDA/CBER
North American Biologicals, Inc. (NABI)
1/2/1982DETECTION OF NON-A, NON-B HEPATITIS
37
1982L-012-1982/0FDA/CBERAbbott Laboratories, Inc.1/15/1982ALLDetection of Non-A, Non-B Hepatitis
38
1982L-106-1982/0NCI/ODAdria Laboratories2/1/1982cis-Platinum (II) Complexes for chemotherapy of neoplastic disease
39
1982L-006-1982/0NCI/ODAbbott Laboratories, Inc.2/24/1982AllLarge Unilamellar Vesicles
40
1982L-040-1982/0NHLBI/COBE Laboratories Inc3/1/1982FLOW-THROUGH CENTRIFUGE
41
1982L-101-1982/0NIA/McNeilab, Inc.4/6/1982WATER SOLUBLE FORMS OF RETINOIDS
42
1982L-001-1982/0NHLBI/P.C. Incorporated4/8/1982Toroidal Coil Planet Centrifuge
43
1982L-004-1982/0NCI/ODCooper Biomedical, Inc.4/12/1982ALL
Monoclonal Antibodies Against Herpes Simplex Virus, Type 1 and 2, Nucleocapsids and Kit
44
1982L-002-1982/0NCI/ODDERMIK LABORATORIES, INC.5/21/1982
Method for use of orally administered 13-cis-retinoic acid treatment of dermatopathies
45
1982L-005-1982/0FDA/CDRHNuclear Associates6/1/1982make use and sellContrast Resoultuion Tissue Equivalent Ultrasound Test Object
46
1982L-007-1982/0NIDDK/Nordisk Gentofte6/7/1982make use and sellDORE/CHAMBERS "INFUSION APPARATUS
47
1982L-008-1982/0NIMH/Electro-Nucleonics, Inc.8/9/1982make, use, and sellSILVER STAINS FOR PROTEIN IN GELS
48
1982L-100-1982/0NCI/Mead Johnson and Company9/17/1982
N-ACETYLCYSTEINE TO PREVENT CARDIAC DAMAGE FROM THE USE OF ANTHRACYCLINES IN CANCER THERAPHY
49
1982L-102-1982/0NEI/
Medical Instrument Research Associates
11/2/1982MACULA DISC CAMERA
50
1982L-105-1982/0DRS/Advanced Technology Labs, Inc.12/1/1982FIBER OPTIC PH PROBE FOR TISSUE MEASUREMENTS
51
1982L-104-1982/0NCI/ODNuclear Medical Systems12/13/1982
METHOD FOR THE IDENTIFICATION AND PURIFICATION OF HUMAN LUNG TUMOR-ASSOCIATED ANTIGEN (HLTAA) AND CLINICAL DETECTION AND DETERMINATION ON THESE ANTIGENS
52
1983L-017-1983/0UM/Advanced Technology Labs, Inc.12/1/1982Optical Sensor of Plasma Constituents
53
1983L-015-1983/0UM/Cardiovascular Devices, Inc.12/8/1982Optical Sensor of Plasma Constituents
54
1983L-100-1983/0NIMH/Cooper Biomedical, Inc.3/4/1983MODIFIED SILVER STAIN FOR PROTEINS IN POLYACRYLAMIDE GEL
55
1983L-104-1983/0UM/Cordis, Corp.3/4/1983OPTICAL SENSOR OF PLASMA CONSTITUENTS
56
1983L-004-1983/0NCI/ODBioqual, Incorporated3/9/1983AllMONOCLONAL ANTIBODIES TO HERPES SIMPLEX VIRUS TYPE 1 POLYPEPTIDES
57
1983L-001-1983/0NCI/DCTDUpjohn Company3/16/1983allSynthesis, Structure, and Antitumor Activity of 5,6 Dihydro-5-Azacytidine
58
1983L-006-1983/0DRS/Advanced Technology Labs, Inc.4/13/1983make, have made, use and sellFiber Optic P02 Probe
59
1983L-007-1983/0NICHD/Beecher Company4/18/1983Non-Invasive Optical Assessment of Platelet Viability
60
1983L-003-1983/0NCI/ODRoche Laboratories, Inc.5/26/1983make use and sell
METHOD FOR THE USE OF ORALLY ADMINISTERED 13-CIS- RETINOIC ACID IN THE TREAMENT OF ACNE
61
1983L-002-1983/0CC/Evergreen Industries, Inc.5/31/1983ALL
Felcalator, an Apparatus and Method For Concentration of Parasite Eggs and Larvae
62
1983L-010-1983/0NCI/CCRBioGenex Laboratories, Inc.6/1/1983all products/methods desribed and claimed in patent rightsProcess for Producing Monoclonal Antibodies Reactive with Human Breast Cancer
63
1983L-016-1983/0DRS/Biomedical Sensors, Ltd.6/29/1983Fiber Optic P02 ProbeFiber Optic PO2 Probe
64
1983L-019-1983/0NCRR/Diametrics Medical Limited6/29/1983Fiber Optic Probe and Dye Fixation by CopolymerizationFIBER OPTIC pH PROBE AND ON DYE FIXATION BY COPOLYMERIZATION
65
1983L-020-1983/0NHLBI/Biomedical Sensors, Ltd.6/29/1983Fiber Optic Carbon Dioxide Partial PressureFIBER OPTIC CARBON DIOXIDE PARTIAL PRESSURE SENSOR
66
1983L-021-1983/0NHLBI/Advanced Technology Labs, Inc.6/29/1983FIBER OPTIC CARBON DIOXIDE PARTIAL PRESSURE SENSOR
67
1983L-012-1983/0NIAID/Genentech. Inc.7/1/1983AllProcess for Using Poxviruses as Vectors for Expression of Foreign Genes
68
1983L-013-1983/0NIAID/Amgen, Inc.8/1/1983AllProcess for Using Poxviruses as Vectors for Expression of Foreign Genes
69
1983L-103-1983/0Ean Tech8/12/1983LICENSED PRODUCT(S) shall mean products and methods described and claimed in PATENT RIGHTS to make, have made, use and sell LICENSED PRODUCTSMULTI-SLAB GEL CASTING AND ELECTROPHORESIS APPARATUS
70
1983L-037-1993/0NCI/DBSZymogenetics, Inc.8/23/1983V-SIS CLONES
71
1983L-009-1983/0NCI/CCRAbbott Laboratories, Inc.8/31/1983allMonoclonal Antibodies Reactive with Human Breast Cancer
72
1983L-005-1983/0NIMH/
Bio-Rad Laboratories, Inc. - Life Sciences Group
9/20/1983make, use & sellSILVER STAINS FOR PROTEIN IN GELS
73
1983L-101-1983/0NIAID/
Cutter Group of Miles Laboratories, Inc.
12/2/1983INACTIVATION OF A LIPID VIRUS
74
1984L-014-1984/0Revlon, Inc.10/6/1983make use and sell
Hepatitis B immune Globuline Used to Inactivate Hepatitis B Virus in Injectable Biological Products
75
1984L-004-1984/0NCI/ODGenDerm Corporation11/16/1983
Method for the use of Orally Administered 13-Cis-Retionic Acid in the treatment of Acne
76
1984L-008-1984/0NCI/DCSCetus Corporation11/29/1983Monoclonal Antibodies Against Non Small Cell Lung Cancer
77
1984L-013-1984/0
Cutter Group of Miles Laboratories, Inc.
12/2/1983
Hepatitis B Immune Globuline Used to Inactivate Hepatitis B Cirus in Injectable Biological Products
78
1984L-003-1984/0NCI/ODSchering AG1/1/1984
ANTICANCER AND ANTIVIRAL ACTIVITY OF 9-B-D-ARABINOFURANOSYL-2-FLUOROADENINE
79
1984L-104-1984/0NCI/ODE.I. du Pont de Nemours & Company1/1/19849-BETA-D-ARABINOFURANOSYL-2-FLUOROADENINE AND DERIVATIVES
80
1984L-106-1984/0NIAID/Immuno-U.S., Inc.1/1/1984Inactivation of a Lipid Virus
81
1984L-007-1984/0NCI/DCSCooper Biomedical, Inc.1/12/1984Monoclonal Antibodies Against Non Small Cell Lung Cancer
82
1984L-005-1984/0NICHD/Sparks Instruments & Academics, Inc.2/1/1984make use and sellTrunk Dynamometer
83
1984L-002-1984/0NCI/ODAllergan, Inc.2/13/1984
Method for the use of orally administered 13-cis-retinoic acid in the treatment of acne
84
1984L-100-1984/0DRS/Instrumentation Labs2/21/1984FIBER OPTIC PO2 PROBE
85
1984L-101-1984/0NIAID/MGI PHARMA, INC4/2/1984
PROCESS FOR USING POXVIRUSES AS VECTORS FOR EXPRESSION OF FOREIGN GENES
86
1984L-012-1984/0NIAID/Microgenics Corporation4/12/1984AllProcess for Using Poxviruses as Vectors for Expression of Foreign Genes
87
1984L-009-1984/0NCI/CCRE.I. du Pont de Nemours & Company6/19/1984
Serological Detection of Antibodies to Retroviruses (HTLV-III) in Sera of Patients with AIDS
88
1984L-010-1984/0NCI/CCRPharmacia-Upjohn Company6/19/1984LICENSED PRODUCT(S) shall mean test kits for detection or assay of antibodies developed from cell line H9/HTLV-IIIB on deposit in the American Type Culture Collection (ATCC) under ATCC No. CRL 8543, that utilize the technology and methods described and claimed in PATENT RIGHTS. DEVELOPMENT PRODUCT(S) shall mean vaccines and all other products except LICENSED PRODUCTS developed from cell line H9/HTLV-IIIB on deposit in the American Type Culture Collection (ATCC) under ATCC No. CRL 8543 identified by LICENSEE that are derived from the technology and methods described and claimed in PATENT RIGHTS.
Serological Detection of Antibodies to Retroviruses (HTLV-III) in Sera of Patients with Aids and Pre-Aids Conditions
89
1984L-011-1984/0NCI/CCRDade Behring Inc.6/19/1984LICENSED PRODUCT(S) shall mean test kits for detection or assay of antibodies developed from cell line H9/HTLV-IIIB on deposit in the American Type Culture Collection (ATCC) under ATCC No. CRL 8543, that utilize the technology and methods described and claimed in PATENT RIGHTS. DEVELOPMENT PRODUCT(S) shall mean vaccines and all other products except LICENSED PRODUCTS developed from cell line H9/HTLV-IIIB on deposit in the American Type Culture Collection (ATCC) under ATCC No. CRL 8543 identified by LICENSEE that are derived from the technology and methods described and claimed in PATENT RIGHTS.
SEROLOGICAL DETECTION OF ANTIBODIES TO HTLV-III IN SER PATIENTS WITH AIDS AND PRE-AIDS CONDITIONS
90
1984L-015-1984/0NCI/CCRAbbott Laboratories, Inc.6/19/1984Licensed Product(s) shall mean test kits for detection or assay of antibodies developed from cell line H9/HTLV-IIIB on deposit in the American TypeCulture Collection (ATCC} under ATCC No. CRt 8543, that utilize the technology and methods described and claimed in PATENT RIGHTS. DEVELOPMENT PRODUCT(S) shall mean vaccines and all other products except LICENSED PRODUCTS developed from call line H9/HTLV-IIIB on deposit in the American Type Culture Collection (ATCC) under ATGC No. CRL 8543 identified by LICENSEE that are der1ved. from the technology and methods described and claim in PATENT RIGHTS.
HUMAN IMMUNODEFICIENCY VIRUSES ASSOCIATED WITH AIDS, A DIAGNOSTIC METHOD FOR AIDS AND PRE-AIDS, A KIT THEREFOR
91
1984L-102-1984/0NIAID/Upjohn Company7/1/1984Process for Using Poxviruses as Vectors for Expression of Foreign Genes
92
1984L-103-1984/0NIDCR/Ventec7/1/1984METHOD OF DETECTING MALIGNANT LESIONS IN THE ORAL CAVITY
93
1984L-001-1984/0NCI/ODSynbiotics Corporation8/21/1984AllMonoclonal Antibodies to Herpes - Hamper, Zweig and Showalter
94
1984L-016-1984/0American Home Products Corporation8/22/1984Sectional Outlet Box
95
1984L-006-1984/0NCI/DCSAbbott Laboratories, Inc.9/1/1984make have made, use, and sellMonoclonal Antibodies against Non-small Cell Lung Cancer
96
1984L-105-1984/0FDA/Hyperthermia Resources/Oncotherm11/15/1984
DIATHERMY AND HYPERTHERMIA TREATMENTS FOR CANCER AND IMPROVED EQUIPMENT THEREOF
97
1985L-017-1985/0NIAID/Roche Diagnostics, GmbH10/1/1984Diagnostics All - foreign rights onlyAnti-insulin Antibody Secreting Cell Lines
98
1985L-018-1985/0NCI/DCS
Mochida Pharmaceutical Company, Ltd.
11/26/1984Monoclonal Antibodies Against Non-Small Cell Lung Cancer
99
1985L-003-1985/0NCI/ODBiox, inc.12/1/1984AllMonoclonal Antibodies Against Herpes Simplex Virus Type 1 and 2
100
1985L-012-1985/0NIAID/Scios, Inc12/1/1984AllProcess for using poxviruses as vectors for expression of foreign genes
Loading...
 
 
 
Sheet1
 
 
Main menu